Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07651917
PHASE4

Effect of Supplemental Oxygen Therapy on Neurocognitive Performance in Healthy Highlanders

Sponsor: University of Zurich

View on ClinicalTrials.gov

Summary

Exposure to high altitudes, defined as locations above 2500 m, has been shown to cause cognitive alternations due to reduced blood oxygenation (SpO2). However, it remains to be determined whether cognitive changes are present in highlanders living at moderate altitudes (2500 m) and whether cognitive alterations are reversible with supplemental oxygen therapy (SOT).

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2026-06-18

Completion Date

2026-07-31

Last Updated

2026-06-16

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Supplemental oxygen therapy

5 L/min supplemental oxygen therapy administered through nasal canula.

OTHER

Sham intervention

5 L/min sham intervention administered through nasal canula.